Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Tadenan

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2000
Review
2000
Objective To systematically review the evidence for the clinical effects and safety of the rye‐grass pollen extract (Cernilton… Expand
2000
2000
PURPOSE Tadenan is a plant extract from Pygeum africanum used in the treatment of benign prostatic hyperplasia, to protect the… Expand
2000
2000
OBJECTIVES To evaluate the effect of Tadenan (TAD; Pygeum africanum extract) pretreatment on the micturition characteristics of… Expand
Highly Cited
1998
Highly Cited
1998
Pygeum africanum extract is available as Tadenan in many countries, including those in central and eastern Europe, for the… Expand
Highly Cited
1997
Highly Cited
1997
Bladder dysfunction secondary to benign prostatic hyperplasia (BPH) is a major affliction associated with ageing. As the disease… Expand
1997
1997
Tadenan® (Debat Laboratories, France) is a plant extract used in Europe for the treatment of micturition disorders associated… Expand
1996
1996
PURPOSE Tadenan is a pharmaceutical agent used in the treatment of BPH. Prior studies demonstrated that pretreatment of rabbits… Expand
1996
1996
PURPOSE Tadenan (DEBAT, Paris, France) is a pharmaceutical agent used in the treatment of benign prostatic hyperplasia (BPH). The… Expand
Highly Cited
1984
Highly Cited
1984
The benign hyperplasia of the prostate is a manifestation of aging, involving the accumulation, within the gland, of… Expand
1977
1977
20 patients with benign prostatic hypertrophy were admitted to a double-blind noncrossover study for evaluation of the effect of… Expand